Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr;85(2):e22166.
doi: 10.1002/ddr.22166.

Berberine attenuates inflammation and oxidative stress and modulates lymphocyte E-NTPDase in acute hyperlipidemia

Reem S Alruhaimi  1 , Maisa Siddiq Abduh  2   3 , Ahmad F Ahmeda  4   5 , Albandari Bin-Ammar  6 , Emadeldin M Kamel  7 , Emad H M Hassanein  8 , Chen Li  9 , Ayman M Mahmoud  10   11
Affiliations

Berberine attenuates inflammation and oxidative stress and modulates lymphocyte E-NTPDase in acute hyperlipidemia

Reem S Alruhaimi et al. Drug Dev Res. 2024 Apr.

Abstract

Hyperlipidemia is a common clinically encountered health condition worldwide that promotes the development and progression of cardiovascular diseases, including atherosclerosis. Berberine (BBR) is a natural product with acknowledged anti-inflammatory, antioxidant, and metabolic effects. This study evaluated the effect of BBR on lipid alterations, oxidative stress, and inflammatory response in rats with acute hyperlipidemia induced by poloxamer-407 (P-407). Rats were pretreated with BBR (25 and 50 mg/kg) for 14 days and acute hyperlipidemia was induced by a single dose of P-407 (500 mg/kg). BBR ameliorated hypercholesterolemia, hypertriglyceridemia, and plasma lipoproteins in P-407-adminsitered rats. Plasma lipoprotein lipase (LPL) activity was decreased, and hepatic 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase activity was enhanced in hyperlipidemic rats. The expression of low-density lipoprotein receptor (LDL-R) and ATP-binding cassette transporter 1 (ABCA1) was downregulated in hyperlipidemic rats. BBR enhanced LPL activity, upregulated LDL-R, and ABCA1, and suppressed HMG-CoA reductase in P-407-administered rats. Pretreatment with BBR ameliorated lipid peroxidation, nitric oxide (NO), pro-inflammatory mediators (interleukin [IL]-6, IL-1β, tumor necrosis factor [TNF]-α, interferon-γ, IL-4 and IL-18) and enhanced antioxidants. In addition, BBR suppressed lymphocyte ecto-nucleoside triphosphate diphosphohydrolase (E-NTPDase) and ecto-adenosine deaminase (E-ADA) as well as NO and TNF-α release by macrophages isolated from normal and hyperlipidemic rats. In silico investigations revealed the binding affinity of BBR toward LPL, HMG-CoA reductase, LDL-R, PSK9, ABCA1, and E-NTPDase. In conclusion, BBR effectively prevented acute hyperlipidemia and its associated inflammatory responses by modulating LPL, cholesterolgenesis, cytokine release, and lymphocyte E-NTPDase and E-ADA. Therefore, BBR is an effective and safe natural compound that might be employed as an adjuvant against hyperlipidemia and its associated inflammation.

Keywords: E-NTPDase; berberine; dyslipidemia; inflammation; oxidative stress.

PubMed Disclaimer

References

REFERENCES

    1. Abduh, M. S., Saghir, S. A. M., Al Hroob, A. M., Bin-Ammar, A., Al-Tarawni, A. H., Murugaiyah, V., & Mahmoud, A. M. (2023). Averrhoa carambola leaves prevent dyslipidemia and oxidative stress in a rat model of poloxamer-407-induced acute hyperlipidemia. Frontiers in Pharmacology, 14, 1134812. https://doi.org/10.3389/fphar.2023.1134812
    1. Aebi, H. (1984). Catalase in vitro. Methods in Enzymology, 105, 121-126. https://doi.org/10.1016/s0076-6879(84)05016-3
    1. Alves-Bezerra, M., & Cohen, D. E. (2017). Triglyceride metabolism in the liver. Compr Physiol, 8(1), 1-8. https://doi.org/10.1002/cphy.c170012
    1. Antar, S. A., Abdo, W., Taha, R. S., Farage, A. E., El-Moselhy, L. E., Amer, M. E., Abdel Monsef, A. S., Abdel Hamid, A. M., Kamel, E. M., Ahmeda, A. F., & Mahmoud, A. M. (2022). Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2/HO-1 signaling in diabetic rats. Life Sciences, 291, 120260. https://doi.org/10.1016/j.lfs.2021.120260
    1. Bagley, J., Yuan, J., Chandrakar, A., & Iacomini, J. (2015). Hyperlipidemia alters regulatory T cell function and promotes resistance to tolerance induction through costimulatory molecule blockade. American Journal of Transplantation, 15(9), 2324-2335. https://doi.org/10.1111/ajt.13351

LinkOut - more resources